Latest News and Press Releases
Want to stay updated on the latest news?
-
Press Release Weekly progress on share repurchase program to cover share plans and reduce capital Kaiseraugst (Switzerland), Maastricht (Netherlands), November 25, 2025 dsm-firmenich, innovators in...
-
PRESS RELEASEArcadis reports transactions under its current share buyback program Amsterdam, 25 November 2025 – Arcadis N.V. (Arcadis), the world’s leading company delivering data-driven sustainable...
-
ABN AMRO presents roadmap for profitable growth and new financial targets for 2028 25 November 2025 Today, ABN AMRO presents the bank’s new strategy and financial outlook for 2026-2028 at its...
-
Sanoma updates its financial targets – aims to deliver high single-digit growth in the Group’s adjusted operating profit in 2026–2030.
-
LONDON, 25 Nov. 2025 (GLOBE NEWSWIRE) -- This is the Start of Day Message for GlobeNewswire. GlobeNewswire is operated by Notified and is designated by the FCA as an approved primary information...
-
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies showing Dupixent significantly...
-
Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025 Halle (Saale) / Munich, Germany, November 25, 2025 - Vivoryon Therapeutics N.V. (Euronext...
-
Approval based on Phase 3 trials showing Dupixent significantly reduced itch and hives at 24 weeks compared to placebo In the EU, there are approximately 270,000 adults and adolescents aged 12 years...
-
CHENGDU, China, Nov. 25, 2025 (GLOBE NEWSWIRE) -- On November 21, the Global Panda Partners Conference 2025, hosted by Xinhua News Agency Sichuan Branch, Xinhua News & Information Center, China...